RT Book, Section A1 Skorecki, Karl L. A1 Cohen, Bruce H. A2 Loscalzo, Joseph A2 Fauci, Anthony A2 Kasper, Dennis A2 Hauser, Stephen A2 Longo, Dan A2 Jameson, J. Larry SR Print(0) ID 1190512385 T1 Mitochondrial DNA and Heritable Traits and Diseases T2 Harrison's Principles of Internal Medicine, 21e YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781264268504 LK accessmedicine.mhmedical.com/content.aspx?aid=1190512385 RD 2024/04/18 AB Mitochondria are cytoplasmic organelles whose major function is to generate ATP by the process of oxidative phosphorylation under aerobic conditions. This process is mediated by the respiratory electron transport chain (ETC) multiprotein enzyme complexes I–V and the two electron carriers, coenzyme Q10 (CoQ10) and cytochrome c, located in the inner mitochondrial membrane. Other cellular processes to which mitochondria make a major contribution include apoptosis (programmed cell death) and additional cell type–specific functions (Table 468-1). The efficiency of the mitochondrial ETC in ATP production is the major determinant of overall body energy balance and thermogenesis. In addition, mitochondria are the predominant source of reactive oxygen species (ROS), whose rate of production is a delicate balance between health and disease and relates to the coupling of ATP production to oxygen consumption. Given the centrality of oxidative phosphorylation to the normal activities of almost all cells, it is not surprising that mitochondrial dysfunction can affect almost any organ system (Fig. 468-1). Until recently, it was thought that disruption of energy production was the source of the pathophysiology in those with mitochondrial dysfunction, but recent evidence suggests that free radical production and the redox state of the mitochondria may play a role as well. Thus, physicians in many disciplines might encounter patients with mitochondrial diseases and should be aware of their existence and characteristics.